CLINICAL TRIALS PROFILE FOR BETOPTIC PILO
✉ Email this page to a colleague
All Clinical Trials for BETOPTIC PILO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00061542 ↗ | Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension | Completed | Alcon Research | Phase 3 | 2003-01-01 | The purpose of this study is to evaluate the safety and efficacy of BETOPTIC S and Timolol Gel-forming solution in pediatric patients. Patients will dose with study drug at 8 am and 8 pm daily for twelve weeks. Patients will have vision tested, slit lamp exam, blood pressure and pulse checks at each visit. Patients will have a dilated fundus exam and corneal measurements taken at first and last visit. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BETOPTIC PILO
Condition Name
Clinical Trial Locations for BETOPTIC PILO
Trials by Country
Clinical Trial Progress for BETOPTIC PILO
Clinical Trial Phase
Clinical Trial Sponsors for BETOPTIC PILO
Sponsor Name